LIGAND PHARMACEUTICALS INC Quarterly Return On Assets in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Ligand Pharmaceuticals Inc quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q3 2024.
  • Ligand Pharmaceuticals Inc Return On Assets for the quarter ending September 30, 2024 was 5.14 %, a 142% increase year-over-year.
  • Ligand Pharmaceuticals Inc annual Return On Assets for 2023 was 6.67 %.
  • Ligand Pharmaceuticals Inc annual Return On Assets for 2022 was -3.34 %, a 175% decline from 2021.
  • Ligand Pharmaceuticals Inc annual Return On Assets for 2021 was 4.46 %.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 5.14 +3.01 +142% Jul 1, 2024 Sep 30, 2024
Q2 2024 5.05 +1.84 +57.3% Apr 1, 2024 Jun 30, 2024
Q1 2024 11.9 +9.35 +361% Jan 1, 2024 Mar 31, 2024
Q4 2023 6.67 +10 Oct 1, 2023 Dec 31, 2023
Q3 2023 2.13 +4.01 Jul 1, 2023 Sep 30, 2023
Q2 2023 3.21 +3.88 Apr 1, 2023 Jun 30, 2023
Q1 2023 2.59 +0.67 +34.9% Jan 1, 2023 Mar 31, 2023
Q4 2022 -3.34 -7.8 -175% Oct 1, 2022 Dec 31, 2022
Q3 2022 -1.88 -7.15 -136% Jul 1, 2022 Sep 30, 2022
Q2 2022 -0.67 -4.38 -118% Apr 1, 2022 Jun 30, 2022
Q1 2022 1.92 -1.13 -37% Jan 1, 2022 Mar 31, 2022
Q4 2021 4.46 +4.7 Oct 1, 2021 Dec 31, 2021
Q3 2021 5.27 +6.51 Jul 1, 2021 Sep 30, 2021
Q2 2021 3.71 +5.51 Apr 1, 2021 Jun 30, 2021
Q1 2021 3.05 +7.11 Jan 1, 2021 Mar 31, 2021
Q4 2020 -0.24 -37.5 -101% Oct 1, 2020 Dec 31, 2020
Q3 2020 -1.25 -37.7 -103% Jul 1, 2020 Sep 30, 2020
Q2 2020 -1.8 -40 -105% Apr 1, 2020 Jun 30, 2020
Q1 2020 -4.06 -46.9 -109% Jan 1, 2020 Mar 31, 2020
Q4 2019 37.3 +27.7 +289% Oct 1, 2019 Dec 31, 2019
Q3 2019 36.4 +25.8 +242% Jul 1, 2019 Sep 30, 2019
Q2 2019 38.2 +23.7 +163% Apr 1, 2019 Jun 30, 2019
Q1 2019 42.8 +21.8 +104% Jan 1, 2019 Mar 31, 2019
Q4 2018 9.59 -12.4 -56.5% Oct 1, 2018 Dec 31, 2018
Q3 2018 10.6 -18.2 -63.1% Jul 1, 2018 Sep 30, 2018
Q2 2018 14.5 -4.3 -22.8% Apr 1, 2018 Jun 30, 2018
Q1 2018 21 +14.9 +244% Jan 1, 2018 Mar 31, 2018
Q4 2017 22 +22.3 Oct 1, 2017 Dec 31, 2017
Q3 2017 28.8 +27.5 +1999% Jul 1, 2017 Sep 30, 2017
Q2 2017 18.8 -19.1 -50.3% Apr 1, 2017 Jun 30, 2017
Q1 2017 6.12 -43.8 -87.7% Jan 1, 2017 Mar 31, 2017
Q4 2016 -0.28 -58.9 -100% Oct 1, 2016 Dec 31, 2016
Q3 2016 1.37 -68.4 -98% Jul 1, 2016 Sep 30, 2016
Q2 2016 37.9 +26 +219% Apr 1, 2016 Jun 30, 2016
Q1 2016 49.9 +45.1 +943% Jan 1, 2016 Mar 31, 2016
Q4 2015 58.7 +52.1 +797% Oct 1, 2015 Dec 31, 2015
Q3 2015 69.7 +65 +1385% Jul 1, 2015 Sep 30, 2015
Q2 2015 11.9 +4.58 +62.7% Apr 1, 2015 Jun 30, 2015
Q1 2015 4.78 -6.91 -59.1% Jan 1, 2015 Mar 31, 2015
Q4 2014 6.54 -4.76 -42.1% Oct 1, 2014 Dec 31, 2014
Q3 2014 4.7 -5.82 -55.4% Jul 1, 2014 Sep 30, 2014
Q2 2014 7.31 -1.15 -13.6% Apr 1, 2014 Jun 30, 2014
Q1 2014 11.7 +11.9 Jan 1, 2014 Mar 31, 2014
Q4 2013 11.3 +11.8 Oct 1, 2013 Dec 31, 2013
Q3 2013 10.5 +7.63 +265% Jul 1, 2013 Sep 30, 2013
Q2 2013 8.46 +9.24 Apr 1, 2013 Jun 30, 2013
Q1 2013 -0.16 -1.18 -116% Jan 1, 2013 Mar 31, 2013
Q4 2012 -0.51 Oct 1, 2012 Dec 31, 2012
Q3 2012 2.88 Jul 1, 2012 Sep 30, 2012
Q2 2012 -0.77 Apr 1, 2012 Jun 30, 2012
Q1 2012 1.02 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.